Literature DB >> 15569418

Peplomycin induces G1-phase specific apoptosis in liver carcinoma cell line Bel-7402 involving G2-phase arrest.

Hong-ying Chen1, Cong-yi Zheng, Guo-lin Zou, Da-xing Xie, Jian-ping Gong.   

Abstract

AIM: To investigate the mechanism of peplomycin (PEP)-induced apoptosis in liver carcinoma cell line (Bel-7402).
METHODS: Growth inhibition by PEP was analyzed using 3- 4,5-Dimethylthiazol-2-yl-2,5-diphenyltetrazolium bromide (MTT) assay. Apoptotic cells were detected using Hoechest 33258 staining, and confirmed by flow cytometric analysis and DNA fragmentation analysis. The expression of cyclin A and B1 were determined by flow cytometry and Western blot. Annexin V assay was measured by flow cytometric analysis.
RESULTS: PEP induced apoptosis and then inhibited cell proliferation in liver carcinoma cell line Bel-7402. Cells treated with PEP 50 mumol/L for 15 h were arrested in G2-phase with dramatical expression of cyclin A and a little change in cyclin B1. Almost all the apoptosis occurred in cells undergoing the G1-phase after treatment for 24 h.
CONCLUSION: Peplomycin induced G1-phase specific apoptosis in Bel-7402 involving G2-phase arrest.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15569418

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  2 in total

1.  A novel DNA intercalator, butylamino-pyrimido[4',5':4,5]selenolo(2,3-b)quinoline, induces cell cycle arrest and apoptosis in leukemic cells.

Authors:  M S Shahabuddin; Mridula Nambiar; Bibha Choudhary; Gopal M Advirao; Sathees C Raghavan
Journal:  Invest New Drugs       Date:  2009-01-14       Impact factor: 3.850

2.  Successful Treatment of Two Cases of Squamous Cell Carcinoma on the Ear with Intra-Arterial Administration of Peplomycin through a Superficial Temporal Artery.

Authors:  Takahiro Haga; Taku Fujimura; Izuho Takeuchi; Masatoshi Deguchi; Setsuya Aiba
Journal:  Case Rep Dermatol       Date:  2014-09-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.